If Uptravi (Selexipag) Isn't Approved by UnitedHealthcare in North Carolina: Formulary Alternatives & Exception Paths
Answer Box: When UnitedHealthcare Denies Uptravi (Selexipag) in North Carolina
UnitedHealthcare requires step therapy before approving Uptravi (selexipag) for pulmonary arterial hypertension. You'll need to try formulary alternatives first—typically PDE5 inhibitors (sildenafil, tadalafil) or endothelin receptor antagonists (ambrisentan, bosentan)—unless you qualify for an exception. If denied